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Promyelocytic leukemia zinc finger protein (PLZF) is a protein involved in various signaling, growth regulatory, and differentiation
pathways, including development/function of some T cells. Here, we aimed at the detection of PLZF during colorectal
carcinogenesis, using immunofluorescence, and at the evaluation of the colocalization of PLZF with CD2 and CD56 positive cells
(T, 𝛾𝛿, NK, and NKT cells), using confocal-microscopy, along colorectal carcinogenesis, since its earliest stages, that is, dysplastic
aberrant crypt foci (ACF). Furthermore, we analyzed PLZF in the normal colonic mucosa (NM) according to anthropometric
parameters of the subject. NM exhibited strong CD56 fluorescent staining. This infiltration was lost in both ACF and colorectal
carcinoma (CRC), while PLZF presence increased from NM to ACF and CRC. Strong association was found between CD56+
colonic mucosa cell infiltration and body mass index. Interestingly, an increased stromal PLZF-reactivity was present in NM of
obese subjects. This study shows that overexpression of PLZF and exclusion of NK cells in dysplastic microenvironment are very
early events in the stepwise sequence leading to CRC and that lower levels of CD56+ cells in NM, together with increased levels of
PLZF+ cells, can be a reflection of colon cancer risk due to obesity.
1. Introduction
The zinc finger and BTB domain containing 16 (Zbtb16) gene,
described in humans since 1993, encodes for promyelocytic
leukemia zinc finger protein (PLZF), a sequence-specific
DNA-binding protein which bears a conserved N-terminal
BTB/POZ repression and multimerization domain, a second
region (RD2) responsible for transcriptional repression, and
aC-terminal with nineC2H2Kruppel-type zinc fingermotifs
that create the DNA-binding domain [1, 2]. Similar to other
members of this family (approximately 60 human BTB/POZ-
zinc fingers have been described, including HIC-1, BCL-
6, Kaiso, FAZF, and LRF), PLZF has generally transcrip-
tional repressor activity; however, PLZF can also activate
transcription. The determinants of activator versus repressor
function have not been defined. The BTB/POZ domain is
also strongly implicated in the control of transcriptional acti-
vation or repression through local chromatin modification
and remodeling. PLZF interacts directlywith nuclear proteins
such as mSin3a, SMRT, and NCoR via conserved residues
in its BTB/POZ domain and, in turn, interacts with histone
deacetylases (HDAC1) [3, 4].
Earlier studies highlighted the role of PLZF in regulating
differentiation. These reports confined the expression of
PLZF to stem cells and early progenitor cells, suggesting
that PLZF is essential for preserving pluripotency and the
ability to self-renew [5–7]. PLZF is expressed at high levels
in undifferentiated, multipotential hematopoietic progenitor
cells, and this expression declined when those cells were
committed to a specific hematopoietic lineage and started
to differentiate. By contrast, overexpression of PLZF turns
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off the production of mature cells, regulating the balance
between proliferation and differentiation [8, 9].
It is now known that PLZF is expressed in many cells of
the body, and several lines of evidence indicate that PLZF
participates in various signaling, growth regulatory, and
differentiation pathways, including hematopoiesis, adipo-
genesis, hippocampal neurogenesis, osteoclastogenesis, and
muscle differentiation, and it is involved in diverse functions,
such as homeostasis, neoplasia, and apoptosis [10, 11].
Recent data have shown that PLZF is expressed only in
specific populations of T cells. PLZF was required for acqui-
sition of the innate-like properties of these cells, such as rapid
cytokine production, ability to produce simultaneously Th1
and Th2 cytokines, and exhibiting an activated phenotype.
Several laboratories reported that PLZF plays critical roles
in the development or function of some cells such as natural
killer cells (NK), natural killer T cells (NKT), gammadelta T
cells (𝛾𝛿 T cells), and memory CD8 T cells [12–15].
NK cells are a subset of lymphocytes which represent 5%
to 20% of peripheral blood mononuclear cells, and they are
defined phenotypically by their expression of CD56 antigen
and lack of expression of CD3 one. NK cells are a component
of the innate immune system, and they have the ability
to both lyse target cells and to provide an early source of
immunoregulatory cytokines. NK cells play an important role
in the defence against viral infections as well as in tumor
surveillance. At present, it is accepted that NK cells are a
subset of lymphocytes with an important role in the early
response to tumors [16, 17].
PLZF has been also identified as a key transcription
factor involved in the development of natural killer T (NKT)
cells. NKT cells are a subset of T cells coexpressing the
T cell receptor (TCR)/CD3 complex along with surface
receptors typical of NK cells. NKT cells are known for their
ability to produce a massive burst of cytokines early in an
immune response. NKT cells are multifunctional, they can
enhance microbial immunity and tumor rejection, suppress
autoimmune disease, and promote tolerance [18].
Gammadelta T lymphocytes (𝛾𝛿T cells) are a small subset
of T cells that possess a distinct T-cell receptor (TCR) on
their surface. They protect epithelial barriers via monitoring
and appropriate destruction of dysregulated or transformed
epithelial cells. PLZF can be induced in polyclonal, immature
but notmature gammadelta T lymphocytes, governing acqui-
sition of “innate” properties [19].
Some studies reported that PLZF affects bodyweight, adi-
posity, lipid profile, insulin sensitivity of skeletal muscle, and
related gene expression. Recent lines of evidence clearly indi-
cate that major pathways relevant for metabolic syndrome
(a condition characterized by clustering of insulin resistance,
dyslipidaemia, obesity, hypertension, and procoagulant state)
converge to this factor [20].
PLZF functions as a transcriptional regulator for cell
cycle progression by binding to the promoter of target genes,
such as those for cyclin A and the interleukin-3 receptor
𝛼 subunit. PLZF causes growth suppression and cell cycle
arrest through its ability to repress expression of a number
of growth promoting genes and protooncogenes. The loss of
PLZF has been related to increased proliferation, invasiveness
and motility, and resistance to apoptosis in different cancer
cell types. PLZF is considered a tumor suppressor gene in
various cell types and tissues. However, little is known about
its putative role in solid tumors [21, 22].
In this study, we aimed at the detection, morphological
localization, and quantification of PLZF in human colonic
mucosa and along colorectal carcinogenesis. We looked for
a colocalization with CD2, a glycoprotein that is expressed
on T, 𝛾𝛿-T, and natural killer (NK) cells [23], and with
CD56, a markers of NK and NKT cells, since the stage of
dysplastic aberrant crypt foci, (ACF) [24, 25], referred to
also as microadenomas, microscopic lesions considered the
earliest events in the multistep process of colorectal carcino-
genesis. Here, we report the substantial expansion of PLZF-
expressing cells during colorectal cancer progression, and this
is regardless of the simultaneous decrease in the NK/NKT
cells content. Furthermore, we analyzed the presence of this
protein in the colonic mucosa of subjects according to body
mass index, in order to assess a potential involvement of this
protein in the definition of colorectal cancer risk.
2. Materials and Methods
2.1. Study Population. Waist circumference and body mass
index (BMI) based on weight and height of patients were
measured from patients who underwent colonoscopy for var-
ious reasons. Seven subjects with anthropometric measures
above the cut-off levels for obesity (BMI≥ 25Kg/m2 andwaist
circumference ≥ 88 cm for women and ≥102 cm for men) and
7 subjects with anthropometric measures under the cut-off
levels of obesity (BMI < 25Kg/m2 and waist circumference
< 88 cm for women and <102 cm for men) were enrolled in
the study.One sample of normal colorectalmucosa (NM)was
collected fromeach of the 14 patients during colonoscopy, and
it was frozen at −80∘C. All patients had normal colonoscopy.
Demographic and anthropometric data of these patients are
shown in Table 1. Furthermore, at least one aberrant crypt
focus (ACF) was removed from each of 10 patients after
operation for colorectal cancer on surgical specimens, after
staining of the mucosa with a 0.1% methylene-blue solution
in saline, and observation under a dissecting microscope
[24, 25], and it was frozen at −80∘C. Finally, a sample of
colorectal cancer (CRC) was collected from 10 patients whom
where operated on for colon or rectal cancer and frozen at
−80∘C, as described above.
All patients enrolled in this study, who underwent
colonoscopy or surgical resection for colorectal cancer at
the University Hospital of Modena, were asked to give an
informed written consent to the study protocol, which was
approved by the Comitato Etico Provinciale di Modena.
2.2. Evaluation of Immunofluorescence by Confocal Micros-
copy. The samples of NM, ACF, and CRC were fixed in 4%
paraformaldehyde in PBS, cryoprotected in 15% sucrose in
PBS, and frozen in isopentane cooled in liquid nitrogen.
Horizontal cryosections of the samples were cut (10 𝜇m
thick), and haematoxylin and eosin staining was performed
on sections to control tissue integrity and histology. After
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Table 1: Demographic and anthropometric data of subjects with normal colonoscopy.
Patient number Age Sex BMI Waist circumference
1 79 M 25.9 103
2 79 F 23 85
3 52 F 24.2 81
4 63 F 21.25 85
5 46 M 31 111
6 41 M 32.5 117
7 46 F 19.9 75
8 68 F 28.66 107
9 65 F 28.84 99
10 56 M 24.3 98
11 64 M 24.16 92
12 73 M 29 109
13 68 M 34.4 116
14 55 M 24.30 97
a treatment with 3% BSA in PBS for 30min at room
temperature, the cryostatic sections were incubated with the
primary antibodies: rabbit anti-zbtb16 (Sigma), mouse anti-
CD2, and mouse anti-CD56 (Dako), diluted 1 : 25 in PBS
containing 3% BSA for 1 h at room temperature.
After washing in PBS, the samples were incubated for
1 h at room temperature with the secondary antibodies
diluted 1 : 20 in PBS containing 3% BSA (sheep anti-mouse
FITC conjugated and goat anti-rabbit TRITC conjugated
(SIGMA)). After washing in PBS and in H
2
O, the samples
were counterstained with 1 𝜇g/mL DAPI in H
2
O and then
mounted with antifading medium (0.21M DABCO and 90%
glycerol in 0.02M Tris, pH 8.0). Negative control samples
were not incubated with the primary antibody. The confocal
imaging was performed on a Leica TCS SP2 AOBS confocal
laser scanning microscope.
Excitation and detection of the samples were carried out
in sequential mode to avoid overlapping of signals. Sections
were scanned with laser intensity, confocal aperture, gain
and black-level setting kept constant for all samples. Optical
sections were obtained at increments of 0.3𝜇m in the 𝑧-axis
and were digitized with a scanning mode format of 512 ×
512 or 1024 × 1024 pixels and 256 grey levels. The confocal
serial sections were processed with the Leica LCS software to
obtain three-dimensional projections. Image rendering was
performed by adobe Photoshop software. The original green
fluorescent confocal images were converted to grey-scale, and
median filtering was performed. An intensity value ranging
from 0 (black) to 255 (white) was assigned to each pixel.
Background fluorescence was subtracted, and immuno-
fluorescence intensity (IF) was calculated as the average for
each selected area. The fluorescence intensity at the selected
areas, linearly correlated with the number of pixels, was
quantitatively analysed using the standard imaging analysis
software of an NIS-Elements system. To each sample was
assigned a code number, and the score, referred to as
immunofluorescence intensity score (IFIS), was determined
by an observer whowas blind to tissue groups during analysis
[26, 27].
2.3. Colocalization Analysis. To examine the cellular local-
ization of PLZF within CD2+ and CD56+ cells, multiple
immunofluorescence staining of rabbit anti-PLZF antibody,
(Sigma) withmouse anti-CD2 andmouse anti-CD56 (Dako),
were applied according to our previously published method.
The samples, processed for multiple fluorescence (DAPI,
FITC, and Cy3), were sequentially excited with the
405 nm/25mW lines of a blue diode laser, the 488 nm/20mW
lines of the Argon laser, and the 543 nm/1.2mW lines of a
HeNe laser.
Optical sections were obtained at increments of 0.3𝜇m in
the 𝑧-axis and were digitized with a scanning mode format
of 512 × 512 or 1024 × 1024 pixels and 256 grey levels. For
colocalization analyses, the different channel images were
acquired independently, and photomultiplier gain for each
channel was adjusted to minimize background noise and
saturated pixels. Once acquired, images were not modified
further.
The degree of colocalization between red (Cy3) and green
signals (FITC) was calculated based on the integrated density
of each signal independently for each different sections.
Manders’ coefficient was calculated with ImageJ using the
JACoP tool [28]. Manders’ coefficient varies from 0 to 1,
corresponding to nonoverlapping images and 100% colocal-
ization between the two images, respectively. The intensity
of fluorescence for each marker was multiplied for the
corresponding Manders’ coefficient, in order to obtain the
normalized colocalization levels.
2.4. Statistical Analysis. All quantitative data for NM, ACF,
andCRC are reported asmean± SE.The difference in average
expression, in the different groups of colorectal lesions,
was tested for statistical significance using Kruskal-Wallis

















































Figure 1: CD2, CD56, and PLZF fluorescence levels along colorectal carcinogenesis. Fluorescence levels of CD2 (a), CD56 (b), and
PLZF (c) immunostaining in normal colorectal mucosa (NM), aberrant crypt foci (ACF), and colorectal carcinoma (CRC), expressed by
immunofluorescence intensity score (IFIS). #𝑃 < 0.05 versus NM; ∗𝑃 < 0.05 versus CRC.
analysis, followed by Student-Newman-Keuls tests.The value
of 𝑃 < 0.05 was chosen to indicate a significant difference.
3. Results
3.1. Fluorescence Analysis of CD2+ and CD56+ Cell Infil-
tration during Colorectal Carcinogenesis. We performed an
immunofluorescence analysis with anti-CD2 antibody on
normal colonic mucosa, ACF, and colorectal cancer. This
adhesion protein can discriminate NK cell, T lymphocytes,
and gammadelta T cells. The number of CD2+ cells was
generally low in normal colonic mucosa (IFIS: 2.7 ± 0.7).
This fact was also evident in ACF (IFIS: 2.6 ± 0.9), despite
a well-documented inflammatory microenvironment pre-
viously reported in these lesions. On the other hand, we
observed an increased level of CD2-associated fluorescence
in colorectal carcinomas (IFIS: 8.2 ± 1.5), and this gain was
statistically significant with respect to NM and ACF (Figures
1(a), 2(a), 2(b), and 2(c)).
By contrast, we observed a very strongCD56 fluorescence
staining in normal colorectal mucosa (IFIS: 64.3 ± 11.1). The
presence of CD56+ cells decreased dramatically inACF (IFIS:
9.4 ± 1.4). Finally, CD56 fluorescent staining was further
reduced in colorectal carcinomas until almost undetectable
(IFIS: 4.2 ± 1.4) (Figures 1(b), 2(d), 2(e), and 2(f)).
3.2. Morphological Analysis of PLZF+ Cell Infiltration and
Spatial Relationship with CD2 and CD56. In samples of
colorectal mucosa, the anti-PLZF antibody was used firstly
to define the spatial and cellular expression of this protein.
Examples of PLZF staining are shown in Figures 2(g), 2(h),
and 2(i). Our experiments consistently showed that PLZF
protein is expressed only in the stromal compartment of
all samples of colonic mucosa and lesions, with no sign of
epithelial staining.
Although there were a few PLZF-positive cells in the
stroma of normal colonic mucosa (IFIS: 16.6 ± 2.4), their
number increased sharply in the neoplastic milieux. Indeed,
we observed a significant increase of the PLZF fluorescence
signals in ACF (IFIS: 33.5 ± 4.8). The number of PLZF+
infiltrating cells remained high in the stroma surrounding
colorectal cancer cells (IFIS: 33.7 ± 3.1) (Figures 1(c) and
2(g)–2(i)).
We also performed double fluorescent staining of PLZF
with CD2 and of PLZF with CD56. The colocalization levels
were measured with theManders’ coefficient values (data not
shown). As shown also in Figure 2, PLZF protein colocalized
with none of the markers, and the proteins were almost
mutually exclusive.
3.3. CD2+, CD56+, and PLZF+ Cell Infiltration in Normal
Colonic Mucosa according to Anthropometric Parameters of
Subjects with Normal Colonoscopy. We divided patients who
underwent colonoscopy according to their anthropometric
parameters (body mass index and waist circumference) in
order to relate the inflammatory content of normal colonic
mucosa, as assessed by the markers used (mainly NK and
NKT cells), with parameters indicative of increased colorectal
cancer risk. All three markers showed differences in their
colonic content on the basis of body composition of the
subject. Particularly, there was a substantial decrease of
CD56+ cells in the normal colonic mucosa of obese subjects
(IFIS: 84.8 ± 17.1 in normal people versus (IFIS: 42.9 ± 10.5




Figure 2: Confocal immunofluorescence staining of colorectal carcinogenesis. Examples of confocal analysis of cryosections of normal
colorectal mucosa (NM), aberrant crypt foci (ACF), and colorectal carcinoma (CRC), labelled by DAPI (blue), PLZF (green), CD2 (magenta),
and CD56 (red). (a)–(c): PLZFwith CD2 inNM (a), ACF (b), and CRC (c). (d)–(f): PLZF and CD56 inNM (d), ACF (e), and CRC (f). (g)–(i):
immunostaining of PLZF alone in NM (g), ACF (h), and CRC (i). Scale bar = 80 𝜇m.
in obese people). These subjects also showed increased levels
of CD2+ cells compared to the levels in the normal colonic
mucosa of normal weight subjects, although the difference
was not significant (IFIS: 2.1 ± 0.7 in normal weight
subjects versus IFIS: 3.5 ± 1.4 in obese subjects). Also PLZF
showed higher expression in normal colonicmucosa of obese
subjects, and the difference was significant (IFIS: 12.7 ± 3.3
in normal weight subjects versus IFIS: 21.5 ± 3.6 in obese
subjects) (Figures 3 and 4).
4. Discussion
In this study, presence, tissue localization, and amount of
PLZF in normal colorectal mucosa were evaluated together
with presence and amount of CD2- and CD56-positive cells.
Furthermore, we also investigated the fluorescence levels of
these proteins in early premalignant lesions of the colonic
mucosa, that is, dysplastic aberrant crypt foci (ACF), and in
colorectal cancer microenvironment.




































Figure 3: CD2, CD56, and PLZF fluorescence levels in normal colorectal mucosa of subjects with normal colonoscopy. Fluorescence levels of
CD2 (a), CD56 (b), and PLZF (c) immunostaining in normal colorectal mucosa of subjects with normal weight (Norm: BMI < 25Kg/m2 and
waist circumference < 88 cm for women and <102 cm for men) and obese subjects (Ob: BMI ≥ 25Kg/m2 and waist circumference ≥ 88 cm
for women and ≥102 cm for men) expressed by immunofluorescence intensity score (IFIS). ∗𝑃 < 0.05 versus Norm.
CD2 is a cell-surface glycoprotein expressed only on T
cells, natural killer (NK) cells, and dendritic cells. It plays
an important role in regulating cell responses; indeed, it can
initiate innate and adaptive immune responses. Here, we
found a small amount of CD2+ cells in normal colorectal
mucosa. An increase in CD2+ cells was found only in
colorectal cancer samples, while the amount of CD2+ cells
remained low in ACF.
Cell surface expression of CD56 phenotypically defines
NK cells and NKT cells. Normal colorectal mucosa exhibited
a strong fluorescent staining of CD56-positive cells. This
infiltration was lost early, since the earliest appearance of
dysplastic epithelium, as in ACF. Moreover, carcinomatous
tissue was poorly infiltrated by CD56+ cells.
Classically, PLZF has been considered a master regulator
of stem cells and early progenitor cells maintenance. How-
ever, several recent evidences point out that PLZF is expressed
inmany cells and tissue of the body such asmyocytes, skeletal
muscles, and renal tubules. A recent paper highlights the
presence of a specific PLZF isoform in intestinal epithelial
cells [29]. Here, we found that the classical PLZF isoform
is detectable by immunofluorescence techniques only in the




Figure 4: Immunofluorescence staining of normal colorectalmucosa. Examples of immunofluorescence of normal colorectalmucosa labelled
by DAPI (blue), CD2 (magenta, (a)-(b)), CD56 (red, (c)-(d)), and PLZF (green, (e)-(f)) in subjects with normal weight (BMI < 25Kg/m2 and
waist circumference < 88 cm for women and <102 cm for men; (a),(c), and (e)) and obese subjects (BMI > 25Kg/m2 and waist circumference
≥ 88 cm for women and ≥102 cm for men; (b), (d), and (f)). Scale bar = 80 𝜇m.
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stromal compartment of colorectal mucosa. The presence
of PLZF+ cells increased from normal colorectal mucosa to
ACF, and it remained high also in colon cancer.
This study is in line with the hypothesis that the immune
response is impaired since the earliest phases of colorectal
cancer development. Indeed, CD2 has a role in both T-cell
adhesion and activation processes [30], and it is involved in
immune surveillance. We observed an increase in the levels
of CD2 only in cancer tissue, when the immune response
is almost unable to fight the tumor. Thus, this is evidence
that colorectal cancer-driven modifications in the immune
response appear since the stage of ACF.
Also, NK cells functionwell as effector cells against tumor
target cells. If NK cells are not capable of infiltrating solid
tumors and preneoplastic lesions, they cannot kill cancer cells
when they appear. Despite others studies that reported that
there is a lowNK-cell numbers in CRC [31], this study shows,
for the first time, that the exclusion of NK cells from the
stroma surrounding the tumor is a very early event in the
stepwise sequence leading to cancer development.
Several works demonstrated that phenotype and function
of lymphocytes expressing PLZF are altered [32]. It has also
been reported that PLZF-deficient cells have a depletion
of the progenitor pool, while they generate an increased
amount of mature progeny. Some authors hypothesized that
overexpression of PLZF can decrease the production of
mature cells in favor of a maintenance of undifferentiated
progenitors [33]. Our study fits this hypothesis, since PLZF
expression increases from early dysplastic lesions, envisaging
a central role for PLZF in themechanism leading to immune-
escape. Indeed, an overexpression of PLZF in dysplastic
microenvironment may lead to decreased number of fully
mature effector cells. Thus, a uneffective cytotoxic reaction
can be permissive toward a neoplastic growth.
The initial mechanism of cancer immunosurveillance is
probably nonspecific, but NK cells seem to play a key role at
this stage. Although the importance of immune surveillance
against cancer, in particular that provided by NK cells, has
been indicated in several papers [16, 17], few studies have
investigated the levels of NK-cell in individuals who have an
increased cancer risk.
There is now strong evidence indicating obesity as a
risk factor for various cancers, particularly colorectal, breast,
uterus, prostate, and pancreatic cancer. Obesity is associated
with a proinflammatory state, and it may be an immune-
impairing condition too. It has been reported that obe-
sity has complex and probably suppressive effects on NK
lymphocytes [34]. We found a strong association between
CD56+ cell infiltration of the normal colonic mucosa and
body mass, and the normal colonic mucosa of obese people
has decreased levels of CD56-immunoreactivity. We also
observed an increased stromal PLZF-reactivity in the normal
colonic mucosa with obesity, prefiguring, as reported by
several studies, a relationship between this protein and the
main energetic and adipogenetic pathways, although the
mechanisms of this association are still unknown.
In conclusion, it has been proposed that there is an
association between natural immunological defence and the
occurrence of common cancers. Our results seem to suggest
that lower levels of CD56+ cells in normal colonic mucosa,
together with increased levels of PLZF+ cells, can mean the
expression of an inhibitory mechanism of colorectal cancer
development. Furthermore, the variation of these markers in
normal colonic mucosa taken during colonoscopy may be
associated with colon cancer risk through alterations induced
by obesity.
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